HomeAGN • CNSX
add
Algernon Pharmaceuticals Inc
Previous close
$0.11
Day range
$0.11 - $0.11
Year range
$0.050 - $0.27
Market cap
2.38M CAD
Avg Volume
29.68K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
.INX
1.26%
1.00%
Financials
Income Statement
Revenue
Net income
(CAD) | Feb 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 980.36K | -18.32% |
Net income | -1.00M | 19.53% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -972.71K | 18.10% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Feb 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 76.28K | -65.42% |
Total assets | 3.95M | -34.48% |
Total liabilities | 3.52M | 43.67% |
Total equity | 437.32K | — |
Shares outstanding | 19.22M | — |
Price to book | 5.50 | — |
Return on assets | -62.01% | — |
Return on capital | -338.07% | — |
Cash Flow
Net change in cash
(CAD) | Feb 2024info | Y/Y change |
---|---|---|
Net income | -1.00M | 19.53% |
Cash from operations | -239.04K | 45.70% |
Cash from investing | -23.12K | -152.13% |
Cash from financing | 265.57K | 1,645.46% |
Net change in cash | 2.11K | 100.45% |
Free cash flow | 106.93K | -54.69% |
About
Founded
2015
Headquarters
Website